Geode Capital Management’s Cytosorbents Corp CTSO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $770K | Sell |
|
|||||
|
2025
Q1 | $614K | Buy |
|
|||||
|
2024
Q4 | $432K | Buy |
|
|||||
|
2024
Q3 | $701K | Buy |
|
|||||
|
2024
Q2 | $306K | Sell |
|
|||||
|
2024
Q1 | $416K | Buy |
|
|||||
|
2023
Q4 | $405K | Hold |
|
|||||
|
2023
Q3 | $686K | Sell |
|
|||||
|
2023
Q2 | $1.33M | Hold |
|
|||||
|
2023
Q1 | $1.25M | Hold |
|
|||||
|
2022
Q4 | $576K | Buy |
|
|||||
|
2022
Q3 | $501K | Buy |
|
|||||
|
2022
Q2 | $805K | Sell |
|
|||||
|
2022
Q1 | $2.24M | Buy |
|
|||||
|
2021
Q4 | $2.91M | Sell |
|
|||||
|
2021
Q3 | $5.66M | Buy |
|
|||||
|
2021
Q2 | $5.24M | Buy |
|
|||||
|
2021
Q1 | $5.71M | Buy |
|
|||||
|
2020
Q4 | $4.53M | Buy |
|
|||||
|
2020
Q3 | $4.2M | Buy |
|
|||||
|
2020
Q2 | $4.53M | Buy |
|
|||||
|
2020
Q1 | $3.26M | Buy |
|
|||||
|
2019
Q4 | $1.38M | Buy |
|
|||||
|
2019
Q3 | $1.77M | Buy |
|
|||||
|
2019
Q2 | $2.29M | Buy |
|
|||||
|
2019
Q1 | $2.44M | Buy |
|
|||||
|
2018
Q4 | $2.44M | Buy |
|
|||||
|
2018
Q3 | $3.67M | Buy |
|
|||||
|
2018
Q2 | $2.73M | Buy |
|
|||||
|
2018
Q1 | $1.02M | Buy |
|
|||||
|
2017
Q4 | $868K | Buy |
|
|||||
|
2017
Q3 | $788K | Hold |
|
|||||
|
2017
Q2 | $546K | Buy |
|
|||||
|
2017
Q1 | $570K | Buy |
|
|||||
|
2016
Q4 | $688K | Buy |
|
|||||
|
2016
Q3 | $805K | Buy |
|
|||||
|
2016
Q2 | $572K | Hold |
|
|||||
|
2016
Q1 | $493 | Sell |
|
|||||
|
2015
Q4 | $701K | Sell |
|
|||||
|
2015
Q3 | $804K | Buy |
|
|||||
|
2015
Q2 | $781K | Buy |
|
|||||
|
2015
Q1 | $1.68M | Buy |
|